Tarpon Springs, FL, United States of America

George Bobotas

USPTO Granted Patents = 10 (Patent Applications = 15)

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 1 (Patent Applications = 6)

Average Co-Inventor Count = 1.6

ph-index = 4

Forward Citations = 196(Granted Patents)

Company Filing History:

4 out of 24

Somerset Pharmaceuticals, Inc.

patents

2 out of 2

Matinas Biopharma Inc.

Reliant Pharmaceuticals, Inc.

patents

Years Active: 2001-2018

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10058521 - Omega-3 pentaenoic acid compositions and methods of use (2018-08-28),

2. 8906964 - Methods of administering compositions comprising docosapentaenoic acid (2014-12-09),

3. 8784886 - Coating capsules with active pharmaceutical ingredients (2014-07-22),

4. 8529952 - Pharmaceutical composition containing fenofibrate and method for the preparation thereof (2013-09-10),

5. 7863331 - Pharmaceutical composition containing fenofibrate and method for the preparation thereof (2011-01-04),

6. 6930119 - Liquid pharmaceutical composition (2005-08-16),

7. 6743824 - Method for preventing and treating peripheral neuropathy by administering selegiline (2004-06-01),

8. 6538036 - Method for preventing and treating peripheral neuropathy by administering selegiline (2003-03-25),

9. 6500868 - Method for preventing and treating peripheral neuropathy by administering selegiline (2002-12-31),

10. 6239181 - Method for preventing and treating peripheral neurophathy by administering selegiline (2001-05-29),

Title: The Innovative Mind of George Bobotas

Introduction

George Bobotas, an inventor based in Tarpon Springs, Florida, has made significant strides in the field of biotechnology with a focus on omega-3 fatty acids. With a total of ten patents to his name, he has contributed valuable innovations that aim to improve health outcomes related to various medical conditions.

Latest Patents

Among his latest patents, one stands out: "Omega-3 pentaenoic acid compositions and methods of use." This invention features an orally administrable composition comprising fatty acids, specifically at least 50% by weight of omega-3 fatty acids, including eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA). The unique ratios established in this composition are aimed at treating or preventing a variety of diseases and conditions, including dyslipidemia, cardiovascular issues, and inflammatory diseases. Another notable patent involves "Methods of administering compositions comprising docosapentaenoic acid," which relates to effectively reducing lipid parameters such as triglycerides and LDL cholesterol through the use of omega-3 docosapentaenoic acid.

Career Highlights

Throughout his career, George Bobotas has worked with reputable companies, including Somerset Pharmaceuticals and Matinas Biopharma. His dedication to research and development has led him to innovate solutions that hold promise in the treatment of complex health issues.

Collaborations

Collaboration has played a crucial role in Bobotas's work, particularly with talented individuals like Abdel Aziz Fawzy and Bruno Criere. These partnerships have enabled the sharing of expertise and ideas, further advancing the research on omega-3 fatty acids and their applications in health.

Conclusion

George Bobotas continues to be a pivotal figure in the innovation landscape, particularly in the realm of omega-3 fatty acids. His impressive portfolio of patents reflects a commitment to improving health through science and technology, paving the way for future advancements in medicine.

This text is generated by artificial intelligence and may not be accurate.